Jouan-Flahault Chrystel, Casset-Semanaz Florence, Minini Pascal
Les Entreprises du Médicament, 88, rue de la Faisanderie, 75782 Paris Cedex 16, France.
Med Sci (Paris). 2004 Feb;20(2):231-5. doi: 10.1051/medsci/2004202231.
Multiplicity of inferences is present in a large majority of clinical trials and conducts to false analyses or interpretation issues. The main risk consists in false positive conclusions. A large number of statistical methods is available for controlling the rate of false positive conclusions. But formal adjustment is not necessary in all cases and depends on the aims of the study.
大多数临床试验中都存在多重推断问题,这会导致错误的分析或解释问题。主要风险在于得出假阳性结论。有大量统计方法可用于控制假阳性结论的发生率。但并非在所有情况下都需要进行正式调整,这取决于研究目的。